Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Escalated Dose Bortezomib Once Weekly Combined with Lenalidomide and Dexamethasone (eVRD) Followed by Lenalidomide Maintenance in First Relapse of Multiple Myeloma (MM). the HOVON 86 Phase 2 Trial

Pieter Sonneveld, MD, Okke de Weerdt, Mark-David Levin, Wendimagegn Ghidey, Edo Vellenga, Saskia K Klein, Jeanette Doorduyn, Marie José Kersten, P.W. Wijermans, MD, PhD, Henk Lokhorst, MD

Blood (2012) 120 (21): 1853.

https://doi.org/10.1182/blood.V120.21.1853.1853

Published: 2012

Journal Articles

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Curly Morris, MD, Simona Iacobelli, Gosta Gahrton, MD, Laurent Garderet, MD, Mary Drake, MBBCh, MD, Anja van Biezen, Mohamad Mohty, Didier Blaise, MD, Xavier Poiré, M.D, Marie José Kersten, Noel-Jean Milpied, MD, Stig Lenhoff, MD, PhD, Nigel H. Russell, MD, J.ürgen Finke, T. M. de Witte, MD, PhD

Blood (2011) 118 (21): 2008.

https://doi.org/10.1182/blood.V118.21.2008.2008

Published: 2011

Journal Articles

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia

Noortje Thielen, Bronno van der Holt, Jan J Cornelissen, MD PhD, Rianne Ammerlaan, Pieter Sonneveld, MD, PhD, Marie José Kersten, J.H. Frederik Falkenburg, Harm Sinnige, Martin Schipperus, Anton Schattenberg, Marinus van Marwijk Kooy, Willem Smit, Gregor Verhoef, Isabel Chu, Peter Valk, Jeroen JWM Janssen, MD PhD, Gert Ossenkoppele, MD, PhD

Blood (2011) 118 (21): 2758.

https://doi.org/10.1182/blood.V118.21.2758.2758

Published: 2011

Journal Articles

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

Annuska M. Glas, Marie José Kersten, Leonie J. M. J. Delahaye, Anke T. Witteveen, Robby E. Kibbelaar, Arno Velds, Lodewyk F. A. Wessels, Peter Joosten, Ron M. Kerkhoven, René Bernards, Johan H. J. M. van Krieken, Philip M. Kluin, Laura J. van't Veer, Daphne de Jong

Blood (2005) 105 (1): 301–307.

https://doi.org/10.1182/blood-2004-06-2298

Published: 2005

Includes: Supplemental data

Journal Articles

Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features

Daphne de Jong, Annuska M. Glas, Lucie Boerrigter, Marie-Christine Hermus, Otilia Dalesio, Els Willemse, Petra M. Nederlof, Marie José Kersten

Blood (2003) 102 (1): 324–327.

https://doi.org/10.1182/blood-2002-09-2822

Published: 2003

Journal Articles

Direct Epstein-Barr Virus (EBV) Typing on Peripheral Blood Mononuclear Cells: No Association Between EBV Type 2 Infection or Superinfection and the Development of Acquired Immunodeficiency Syndrome–Related Non-Hodgkin’s Lymphoma

Debbie van Baarle, Egbert Hovenkamp, Marie José Kersten, Michèl R. Klein, Frank Miedema, Marinus H.J. van Oers

Blood (1999) 93 (11): 3949–3955.

https://doi.org/10.1182/blood.V93.11.3949

Published: 1999

NARROW

Escalated Dose Bortezomib Once Weekly Combined with Lenalidomide and Dexamethasone (eVRD) Followed by Lenalidomide Maintenance in First Relapse of Multiple Myeloma (MM). the HOVON 86 Phase 2 Trial

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features

Direct Epstein-Barr Virus (EBV) Typing on Peripheral Blood Mononuclear Cells: No Association Between EBV Type 2 Infection or Superinfection and the Development of Acquired Immunodeficiency Syndrome–Related Non-Hodgkin’s Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Escalated Dose Bortezomib Once Weekly Combined with Lenalidomide and Dexamethasone (eVRD) Followed by Lenalidomide Maintenance in First Relapse of Multiple Myeloma (MM). the HOVON 86 Phase 2 Trial

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features

Direct Epstein-Barr Virus (EBV) Typing on Peripheral Blood Mononuclear Cells: No Association Between EBV Type 2 Infection or Superinfection and the Development of Acquired Immunodeficiency Syndrome–Related Non-Hodgkin’s Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only